期刊文献+

B超引导下经皮肝穿刺门静脉及瘤体内药物联合治疗肝癌及控制其肝内播散 被引量:3

Effective of Combined Chemotherapy by Percutaneous Transhepatic Intraportal Venous and Intratumor Infusion(CPTIII) for the Patients with Hepatocellular Carcinoma under UltrasoundGuided
暂未订购
导出
摘要 目的 分析B超引导下经皮肝穿刺门静脉及瘤体内药物联合治疗 (CPTIII)肝癌及控制其肝内播散的疗效。方法  12例肝癌伴门静脉癌栓已失去手术机会的中晚期肝癌患者行 3次CPTIII,每次间隔 7天。结果 B超复查 :首次CPTIII后 7天所有患者门静脉癌栓均有缩小 ,完成 3次CPTIII后 7天 7例完全消失 ,5例明显缩小 ,缩小率和消失率分别为 10 0 %及 5 8.3% ,所有肝内 <2 .6cm的癌灶均消失 ,10cm以上主癌灶显著缩小 ,未见新灶 ;B超引导下穿刺主癌灶行针吸细胞学检查仅见坏死组织。患者一般情况好转 ,食欲增加 ,腹胀减轻 ,腹水不同程度消退 ,近期临床效果显著。结论 CPTIII操作简单、安全、适应证广 。 Objective To study the effect of CPTIII.Methods Twelve patients with hepatocellular carcinoma and tumor thrombus of portal vein were studied once a week for three times.Results Ultrasonographic examination revealed that 7 days the rates of shrinkage and disappearance of potal thrombosis were 100% and 58.3% respectively after the third CPTIII,the portal venous tumor thrombus and the tumor less than 2.6cm in patients disappeared,the size of tumor more than 10cm decreased strikingly.The cytological examination from the liver tumor revealed some nectotic tissue without cancer cell.Conclusion The general condition of patients was improved.Abdominal distention and ascites were reduced.CPTIII is a simple,safe and effective method and clinical for patients with hepatocellular carcinoma.
出处 《苏州医学院学报》 2000年第7期635-637,共3页 Acta Academiae Medicinae Suzhou
关键词 肝癌 肝内播散 B超引导 经皮肝穿刺 门静脉 hepatocellular carcinoma intrahepatic metastasis portal vein intratumor combined chemotherapy
  • 相关文献

参考文献8

二级参考文献5

  • 1刘崎,贾雨辰,贺佳,王振堂,田建明,叶华,陆建平,王飞,杨继金,孙飞,陈栋,林琳.肝癌合并门脉癌栓的化疗栓塞治疗[J].中华放射学杂志,1995,29(4):239-242. 被引量:82
  • 2刘崎 贾雨辰 等.肝癌侵犯门静脉的影像表面及其临床意义[J].中华放射学杂志,1991,25:152-155.
  • 3Chung J W,AJR,1995年,165卷,315321页
  • 4刘崎,中华放射学杂志,1995年,29卷,239页
  • 5刘崎,中华放射学杂志,1991年,25卷,152页

共引文献67

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部